Amgen (AMGN) Other Operating Expenses (2009 - 2026)

Amgen (AMGN) has reported Other Operating Expenses for 18 consecutive years, with $2.6 billion the latest figure, recorded in Q1 2026.

• In Q1 2026, Other Operating Expenses fell 30.73% year-over-year to $2.6 billion; the TTM figure through Mar 2026 stood at $12.2 billion (down 10.42% YoY), while the FY2025 annual figure was $13.3 billion, up 1.85% from the prior year.
• Other Operating Expenses came in at $2.6 billion for Q1 2026 at Amgen, down from $3.1 billion in the prior quarter.
• The five-year high for Other Operating Expenses was $3.8 billion in Q1 2025, with the low at $1.6 billion in Q1 2022.
• Average Other Operating Expenses over 5 years is $2.7 billion, with a median of $3.1 billion recorded in 2025.
• Across the five-year window, Other Operating Expenses plunged 36.51% in 2022 and surged 81.96% in 2023, its largest moves.
• Year by year, Other Operating Expenses stood at $1.7 billion in 2022, then soared by 81.96% to $3.1 billion in 2023, then rose by 1.8% to $3.2 billion in 2024, then retreated by 3.81% to $3.1 billion in 2025, then slipped by 13.79% to $2.6 billion in 2026.
• According to Business Quant data, Other Operating Expenses over the past three periods registered $2.6 billion, $3.1 billion, and $3.4 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.